Science Version
-
The adaptive (aka “acquired”) immune system: from friend to foe
-
Chronic inflammation (CI): “Enemy #1” (Part 2: Pharmacology and pharmacodynamics)
-
Chronic inflammation (CI): “Enemy #1” (Part 3: A multisystem pathology)
-
Autoimmune disease: When self becomes the villain (Part 1: Etiologies)
-
Autoimmune disease: When self becomes the villain (Part 2: Female bias)
-
Autoimmune disease: When self becomes the villain (Part 3: Clinical considerations)
-
Immunotherapeutics (Monoclonal antibodies and biologics) (741 words)
-
Immunotherapeutics (cellular and genetic) procedures (Part 2: Homograph [allograph] transplantation)
-
Immunotherapeutics (cellular and genetic) procedures: (Part 3: Genetic engineering/modifications)
-
Immunotherapeutic (cellular and genetic) procedures (Part 5: CRISPR-Cas9 [gene editing] therapy)
-
Cancer: Immunology’s cruelest enemy and greatest challenge (Part 1: Epidemiology)
-
Cancer: Immunology’s cruelest enemy and greatest challenge (Part 2: Etiologies)
-
Cancer: Immunology’s cruelest enemy and greatest challenge (Part 3: Microbiome, XCI and microRNA)
-
Cancer: Current treatment considerations (Part 4: Combination strategies in cancer immunotherapy)
-
Immunology’s role in pandemics, infectious disease and COVID-19 (Part 3: Clinical considerations)
-
Immunology’s role in public health considerations and recommendations